The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 02, 2017

Filed:

Oct. 15, 2012
Applicant:

Nestec S.a., Vevey, CH;

Inventor:
Assignee:

Nestec S.A., Vevey, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 35/745 (2015.01); A61K 31/202 (2006.01); A61K 31/702 (2006.01); A61K 31/7004 (2006.01); A61K 31/7016 (2006.01); A23L 33/00 (2016.01); A23L 33/115 (2016.01); A23L 33/135 (2016.01); A23L 33/21 (2016.01);
U.S. Cl.
CPC ...
A61K 35/745 (2013.01); A23L 33/115 (2016.08); A23L 33/135 (2016.08); A23L 33/21 (2016.08); A23L 33/40 (2016.08); A61K 31/202 (2013.01); A61K 31/702 (2013.01); A61K 31/7004 (2013.01); A61K 31/7016 (2013.01); A23V 2002/00 (2013.01); A23V 2200/00 (2013.01);
Abstract

The invention discloses a composition comprising at least one long chain polyunsaturated fatty acid, at least one probiotic and a mixture of oligosaccharides, said mixture containing at least one of lacto-N-neotetraose (LNnT) and lacto-N-tetraose (LNT), at least one N-acetylated oligosaccharide different from LNnT and LNT, at least one sialylated oligosaccharide and at least one neutral oligosaccharide, for use in increasing insulin sensitivity and/or reducing insulin resistance. This composition optionally further comprises 2'-fucosyllactose (FL). This composition is particularly adapted for use in infants who were born preterm and/or who experienced IUGR, in pregnant women suffering from gestational diabetes and in children, adolescents, and adults suffering from insulin resistance and/or type II diabetes.


Find Patent Forward Citations

Loading…